key: cord-1042874-3qv5l1xl
authors: Häusler, Martin; Kleines, Michael
title: The SARS‐CoV‐2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10–19 years, middle‐aged males, or elderly individuals
date: 2022-03-10
journal: J Med Virol
DOI: 10.1002/jmv.27682
sha: ce5fdd2aa8b453e0c37ae603af142693eb3d7e0a
doc_id: 1042874
cord_uid: 3qv5l1xl

Many epidemiological aspects of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemics, particularly those affecting children, are still sparsely elucidated. Data on the first pandemic phase during the year 2020 indicated that children might serve as a virus reservoir. We now analyzed data on more than 530 000 SARS‐CoV‐2 polymerase chain reaction (PCR) and 12 503 anti‐SARS‐CoV‐2 antibody tests performed in the west of Germany until Week 4 of 2021. We show that children of at least 10 years of age may play a prominent role in the pandemic showing highest PCR‐positive rates in the first (Weeks 28–35), second (Weeks 42–48), and third wave (Week 50 of 2020–Week 2 2021) of the second pandemic phase, although the waves were not mainly initiated by children. The waves' kinetics differed even in nearby cities. Low PCR‐positive rates were confined to areas of lower population density. PCR‐positive rates were higher among middle‐aged males compared with women and among very old females compared with males. From Week 25, seroprevalence rates slowly increased to 50%, indicating ongoing virus activity. In conclusion, the SARS‐CoV‐2 pandemics is characterized by many local but interacting epidemics, initiated and driven by different social groups. Children may not be the main initiators of virus spreading but older children may significantly affect the course of the pandemic. High population density is associated with higher SARS‐CoV‐2 incidence.

The impact of children for the course of the pandemic is still a matter of discussion. 1, 2 This concerns the general susceptibility of children towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 3 their impact on viral transmission, [3] [4] [5] the viral loads in pediatric respiratory specimen compared with adults, [6] [7] [8] [9] [10] [11] and the time spans of viral shedding compared with adults 9,12 or within different pediatric age groups. 13 Hereby, during the first phase of the pandemic, transmission rates from children to further contact persons have been reported to range from 0.5% to 20%. 5, 14 Although longitudinal epidemiological data are important to understand the course of the SARS-CoV-2 pandemic, only few studies have provided longitudinal data spanning a longer period of time. Mensah et al. 15 reported on SARS-CoV-2 infection rates among British school children between July and December 2020, based on polymerase chain reaction (PCR) data. They found an increase of overall positive rates with age. Although low in summer, infection rates increased from August, before school reopening. Young adults were affected earlier than younger children. Despite keeping schools open during the British national lockdown in November 2020, infection rates decreased in school-age children so that schools might not be responsible for driving the pandemic. Leeb et al. 16 described pediatric SARS-CoV-2 incidence rates in the United States as proven by PCR testing. Higher incidences were found among adolescents of 12-17 years compared with 5-to 11-year-old-children. From March 2020 to July 2020, incidences increased continuously, followed by a plateau in August and a decrease in September 2020. 16 Lim et al. 17 studied seroprevalence rates in different regions of the United States between March and August 2020, showing marked time-and regionspecific differences. As antibody titers decreased over time, they suggested that seroprevalence estimates might underestimate the true cumulative incidence of SARS-CoV-2 infections. 17 Based on longitudinal antibody studies performed between January 2020 and February 2021 among German children between 1 and 10 years, Hippich et al. 18 reported on positive rates of up to 8%, which was higher than during PCR studies and explained by frequently asymptomatic pediatric infections. Based on serological studies from children below 18 years of age in Missisippi (USA), Hobbs et al. 19 calculated a continuous increase of seroprevalence rates between April and September 2020 to about 18% with no difference between boys and girls.

People of color, [19] [20] [21] [22] [23] people with low socioeconomic status, [22] [23] [24] [25] families with many members, 26 middle-aged men, 27 and people from areas with higher population densities 28,29 seem to have higher infection rates. A low socioeconomic status 25, 30, 31 and male gender 27 may further be associated with a poorer prognosis.

Whereas PCR studies detect acute infections, antibody studies may mirror the general course of the pandemic and the effect of vaccinations. IgM and IgG anti-SARS-CoV-2 antibodies may already be detectable within 1 week after symptom onset and show an increase of detection rates until Weeks 2-4 (IgM) or Weeks 4-8 (IgG), which is followed by a decrease during the following months. [32] [33] [34] More severely affected patients seem to develop antibodies earlier. 35, 36 Typically, IgG anti-SARS-CoV-2 becomes positive before the disappearance of viral shedding. 13, 37 Similar to IgM, IgA-type antibodies may become detectable before IgG-type antibodies and may decrease more rapidly. 36 Heterogeneous positive rates for anti-SARS-CoV-2 antibodies have been described at similar times in different countries, which may mirror local particularities of the pandemic and the use of different test systems. 38 As different test systems do not show identical results, simultaneous application of different test systems has been recommended to achieve highest detection rates. 33 Based on PCR data of a large private laboratory and of the University Hospital RWTH Aachen laboratory, we have recently shown for the first phase of the SARS-CoV-2 pandemic that children, although not driving spreading of the virus, might serve as viral reservoirs, as they did not show a similar marked decline of positive rates compared with adults. 39 We also found that these data were representative of the situation in Germany. We now wanted to know whether differences regarding the SARS-CoV-2 infection between children and adults were also present in the second phase of the pandemic focusing on an even larger cohort of patients. We further focused on differences between males and females, different regions and different population densities. PCR studies were performed as reported previously. 39 Antibody data were available from studies performed on 12 503 samples in the same area and during the same period of time. The Elecsys ® Anti-SARS-CoV-2 S kit (Roche) targeting IgM/IgA/IgG antibodies to nucleocapsid protein was used for determination of total antibody levels and the Anti-SARS-CoV-2-ELISA test (Euroimmun) was used for determination of IgG and IgA antibodies. Application of both test systems has repeatedly been reported in the literature. 33, 37 The study was approved by the Ethics committee of the Medical Men have been reported to be more seriously affected by SARS-CoV-2 infections. 40 We therefore compared overall positive rates among 278 753 females and 218 726 males in different 1-year age groups ( Figure 4 ). Overall positive rates were similar among male and female children up to 19 years of age but higher among males compared with females between 20 and 70 years of age. From 90 years of age, overall positive rates among women were higher than those among men.

During the first phase of the pandemic, positive rates observed in ambulatory and hospital settings differed markedly. 39 Including a much larger number of investigations performed between Week 7 of 2020 and Week 4 of 2021 ( Figure 5 ), we found that irrespective of age, positive rates were always lower in patients tested in hospitals compared with ambulatory settings. Within the ambulatory or hospital group, respectively, positive rates among different age groups showed very similar patterns with lower rates among young children. When additionally distinguishing between male and female patients ( Figure S4 ), we found that only males of 20-60 years of age tested in ambulatory settings showed markedly higher overall positive rates than women. They even showed highest positive rates compared with nearly all other age or gender groups. In addition, only men of about 60-80 years of age studied in hospitals showed higher positive rates than women.

To study whether higher positive rates among male adults were consistent throughout the pandemic, we calculated the positive rates for 50-to 54-year-old males and females, not differentiating between ambulatory or not ambulatory patients ( Figure S5 ). During most weeks of the pandemic, 50-to 54-year-old males showed higher positive rates than females.

To evaluate whether higher overall positive rates might also be To evaluate whether testing for one antibody could substitute testing for another type of antibody, we first analyzed 151 data sets where data from all three assay types were available for each patient (Table S1 ). In this analysis, total antibody tests were always positive when IgG-type antibodies were positive. Total antibodies, however, proved positive more frequently than IgG antibodies, which for part may be due to the additional presence of IgA and/or IgM type antibodies.

In a second approach, we focused on data sets where only two antibody assays had been performed for each patient (IgG vs. IgA, IgG vs. total antibodies, and IgA vs. total antibodies; Table S2 ). Similar to the findings in Table S1 , testing for total antibodies proved positive in 98% of studies where IgG-type antibodies proved positive, whereas testing for total antibodies in general proved positive more frequently than testing for IgG antibodies. This also could be for part explained by the presence of IgA-type antibodies. In a small proportion of patients, IgA-type antibodies were positive, whereas total antibodies were not. Therefore, testing for total antibodies may, for a large extent, substitute for testing for IgG but not for IgA antibodies. We also studied antibody-positive rates among different age groups differentiating between men and women. Overall positive rates of females and males were similar between age 0 and 74 years of age ( Figure S6 ). From age 75 years, positive rates increased. In 9 of the 11 5-year age groups describing the age period from 20 to 74 years, men showed higher antibody-positive rates than women, which complies with the above-described PCR data. No male predominance was found below 15 years and above 75 years of age.

To evaluate whether distinct antibody subtypes were predominant in distinct age groups positive rates for IgA-type, IgG-type, and total antibodies were plotted against different 5-year age groups and compared with the number of tests performed in these age groups.

As shown in Figure S7 , younger patients tended to show lower positive rates for IgA-type antibodies than for IgG-type or total antibody studies. From age 30 to 79 years, positive rates of the three different antibody test were very similar. Highest positive rates in general were observed among patients from 75 years of age. Children and older persons had been tested considerably less frequently for anti-SARS-CoV-2 antibodies than middle-aged patients.

To study whether different age groups differed with regard to the distribution of their antibody titers, positive antibody titers were classified in a semiquantitative fashion, leading to titers of <10, 10-19, 20-29, 30-39, and so on. Then the cumulative proportions of these groups were depicted for each age group and for the three tests. Due to the low test numbers in young and old persons, reliable data were available between 15 and 84 years of age only. For all three tests, young age groups showed low antibody titers more frequently than older age groups ( Figure S8a-c) .

We finally compared samples for which both PCR and antibody data were available (Table S3 ). In the majority of PCRpositive samples, antibodies to SARS-CoV-2 were also detected.

This share was 78% of the PCR-positive samples for the total antibody test, 76% for the IgG antibody test, and 64% for the IgA antibody test. Similar to the first phase of the pandemic, less PCR (and antibody) tests had been performed among children and older persons ( Figures S1 and S7) , 39 and absolute test numbers decreased in January 2021, although overall positive rates were still high in different age groups ( Figure S1 ) and viral mutations were emerging.

The here described second phase of the pandemic consisted of three different waves, which showed increasing infection rates and were each followed by an only partial decrease of positive rates ( Figure 2 ). The waves' kinetics were not equal for different regions or different age groups. As depicted in Figure S2 , even in nearby cities maximum infection rates occurred at different points of time.

Moreover, whereas overall positive rates among children below 10 years were particularly low, those of 10-to 19-year-old patients were particularly high ( Figure 2 ) and peak infection rates among preschool children were lower than those among school children (Figure 3 ). This Men have been reported to be more severely affected by Sars-CoV-2. In line with these data, overall positive rates were higher among 20-to 65-year-old men than among age-matched women. 27 Endocrine and immunological gender-specific differences have been discussed in this context. 44, 45 Among the here reported patients, however, lower female infection rates did not only affect the premenopausal but the entire working lifetime which argues against this hypothesis. According to the literature, the pattern of social contacting may also affect viral transmission. Hereby highest transmission rates are frequently predicted for respiratory infections in school children and young adults. 46, 47 The patterns of social contact may differ between different age groups, with regard to the involvement of family or nonfamily members, the presence of physical contact, and whether contacts occur during school, work, or leisure times. [47] [48] [49] [50] Men, for example, show higher employment rates than women (for details, browse eurostat.ec.europa.eu) but experience a decrease of social 51 and of physical activities 52 after retirement. In general, from age 65 years, the number of contacts involving several persons (clustering) drops. 53 Whereas the rate of social contacting is stable throughout the life span for family members, it continuously decreases for nonfamily members with an accelerated decrease after 70 years of age. 48 Therefore, differences in social contacting between working life and retirement may be one further cause for differences between male and female infection rates.

High male positive rates were restricted to ambulatory tests and overall positive rates in hospitals were generally lower than those from ambulatory settings. This may be related to the fact that hospitals preferentially harbor noninfected persons plus selected persons with severe SARS-CoV-2 infections. Moreover, during this phase of the pandemic, SARS-CoV-2 infection rarely led to hospital admission of middle-aged men compared with older persons. These biases must be considered when including hospital data into epidemiological studies.

Socioeconomic factors 25 and higher population densities 28, 29 may also affect infection rates. According to the here reported findings, population density alone does not determine spreading of the virus as high SARS-CoV-2 infection rates were also present in regions of low population densities (Figure 7 ). All areas with population densities above 4000 inhabitants per km 2 , however, showed overall infection rates above 6% so that living closely together may promote virus spreading.

Whereas PCR studies detect acute infections, antibody studies may provide a view on the general course of the pandemic. For this study, data for a total antibody test and for an IgA-and IgG-antibody test were available. Whereas the total antibody test detected quite all persons tested positive by the IgG test, the IgA test did not substitute for the IgG test or the total antibody test, respectively (Tables S1   and S2) Because of the number of data available, reliable conclusions for antibody titers could be drawn for patients between 15 and 84 years only ( Figure S8a-c) . With age, the proportion of patients with low total, IgG, and IgA anti-SARS-CoV-2 antibody titers decreased. As lower antibody titers may mirror less severe SARS-CoV-2-related clinical disease 35, 37 or a weaker antibody response this may be of relevance for immunization strategies.

We finally compared samples from which both PCR and antibody data were available (Table S3) . Independently from the test system used, the majority of PCR-positive samples also proved antibody positive, which confirms that seroconversion occurs early after primary infection 32, 34, 36, 54 and may be necessary for viral clearance. 13, 37 In contrast to literature data, the share of IgA antibodies was not higher during this early phase of the infection than of IgG antibodies.

Our results indicate that the general kinetics of the SARS-CoV-2 pandemic in Germany represents the sum of a large number of local but interacting epidemics. Molecular data of whole genome sequencing of SARS-CoV-2 is available for Germany (e.g., Gisaid. org). Such data could be used to verify our observation on the molecular level. Unfortunately, the sequences are only available on the federal and state level. For the time period investigated by us up to the end of January 2021, <2000 sequences are available for the state of North Rhine-Westphalia. This is not enough data to investigate the clonal expansion of SARS-CoV-2 strains on county or city level. Thus, our observation could not be verified based on molecular data due to the lack of available sequences. However, serological data on state level support the hypothesis of interacting local epidemics, as the prevalence of positive antibody findings differed significantly between regions of Bavaria (tests performed between April to July 2020; prevalence range 0.15%-1.63%). 55 Further, the data were collected retrospectively, not prospectively.

This results in an overrepresentation of symptomatic patients, as asymptomatic individuals were probably tested less frequently. irrespective from the infectious agent, pediatric aspects should be addressed as consequently as those from adults, together with aspects of gender and of social contacting. This will enable to develop more precise pediatric recommendations, to avoid extensive social restrictions and to provide more effective infection control.

We are grateful to Dr. Josef van Helden (MVZ Dr Stein & Colleagues Monchengladbach Laboratory, Mönchengladbach, Germany) for kindly providing us the anonymized data set. We gratefully acknowledge the authors from originating and submitting laboratories of sequence data of the GISAID database. No funding was available for this study.

The authors declare no conflicts of interest.

The study was approved by the Ethics committee of the Medical Faculty of RWTH Aachen University (CTC-A 20-295).

Both authors contributed to the conceptualization of the study, data curation, data analysis, data validation, data visualization, writing of the original draft, revision and editing of the manuscript, and approved the final version of the manuscript.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0002-8433-8919

Michael Kleines http://orcid.org/0000-0003-4866-6007

Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis

Are children and schools a COVID-19 threat?

The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19

Household SARS-CoV-2 transmission and children: a network prospective study

Symptoms and transmission of SARS-CoV-2 among children-Utah and Wisconsin

Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults

Children and adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads

Role of children in household transmission of COVID-19

SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults

The association of viral load and disease severity in children with COVID-19

Duration of viral clearance in children with SARS-CoV-2 infection in Rajasthan

Kinetics of viral clearance and antibody production across age groups in children with severe acute respiratory syndrome coronavirus 2 infection

Transmission of SARS-CoV-2 infection by children: a study of contacts of index paediatric cases in India

SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance

COVID-19 trends among school-aged children-United States

Changes in SARS CoV-2 seroprevalence over time in ten sites in the United States

A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave

Estimated SARS-CoV-2 seroprevalence among persons aged <18 years-Mississippi

SARS-CoV-2 positivity rate for Latinos in the Baltimore-Washington, DC region

SARS-CoV-2 positivity rates among children of racial and ethnic minority groups in Mississippi

Racial and/or ethnic and socioeconomic disparities of SARS-CoV-2 infection among children

Social determinants of COVID-19 incidence and outcomes: a rapid review

Spatial analysis of COVID-19 incidence and the sociodemographic context in Brazil

Socioeconomic status determines COVID-19 incidence and related mortality in

SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: a population-based seroepidemiological survey in Lima

Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age

Predictors of laboratory-positive COVID-19 in children and teenagers

The socio-economic determinants of COVID-19: a spatial analysis of German county level data

Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study

Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status

Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay

An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population

Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients

Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital

SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS

Seroprevalence of SARS-CoV-2 in Guilan Province

Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany

Biological sex impacts COVID-19 outcomes

Seroprevalence of SARS-CoV-2 IgG antibodies in Corsica (France)

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance

Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges

Identification of biomarkers, new treatments, and vaccines for COVID-19

Impact of sex and gender on COVID-19 outcomes in Europe

Using data on social contacts to estimate age-specific transmission parameters for respiratoryspread infectious agents

Social contacts and mixing patterns relevant to the spread of infectious diseases

Getting together: social contact frequency across the life span

Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases

Age trends in daily social contact patterns

Short-term and medium-term impact of retirement on sport activity, self-reported health, and social activity of women and men in Poland

Life-change events and participation in physical activity: a systematic review

Social encounter networks: characterizing Great Britain

Dataset for longitudinal evaluation of the Abbott Architect SARS-CoV-2 IgM and IgG assays in a pediatric population divided by age

A public health antibody screening indicates a 6-fold higher SARS-CoV-2 exposure rate than reported cases in children

The SARS-CoV-2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10-19 years, middle-aged males, or elderly individuals